tiprankstipranks
Blurbs

Analysts Have Conflicting Sentiments on These Healthcare Companies: Becton Dickinson (BDX), Biogen (BIIB) and AmerisourceBergen (ABC)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Becton Dickinson (BDXResearch Report), Biogen (BIIBResearch Report) and AmerisourceBergen (ABCResearch Report).

Becton Dickinson (BDX)

J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Becton Dickinson on February 3 and set a price target of $285.00. The company’s shares closed last Friday at $269.98.

According to TipRanks.com, Marcus is a 4-star analyst with an average return of 14.3% and a 55.6% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Edwards Lifesciences.

Becton Dickinson has an analyst consensus of Hold, with a price target consensus of $286.63, representing a 5.8% upside. In a report issued on February 3, UBS also maintained a Hold rating on the stock with a $280.00 price target.

See today’s best-performing stocks on TipRanks >>

Biogen (BIIB)

J.P. Morgan analyst Cory Kasimov maintained a Hold rating on Biogen on February 3 and set a price target of $236.00. The company’s shares closed last Friday at $214.59, close to its 52-week low of $212.56.

According to TipRanks.com, Kasimov is a 5-star analyst with an average return of 18.4% and a 55.2% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, Ultragenyx Pharmaceutical, and BioMarin Pharmaceutical.

Currently, the analyst consensus on Biogen is a Moderate Buy with an average price target of $263.58, implying a 20.2% upside from current levels. In a report issued on January 20, Barclays also maintained a Hold rating on the stock with a $244.00 price target.

AmerisourceBergen (ABC)

J.P. Morgan analyst Lisa Gill maintained a Buy rating on AmerisourceBergen on February 3 and set a price target of $153.00. The company’s shares closed last Friday at $140.24, close to its 52-week high of $143.61.

According to TipRanks.com, Gill is a 5-star analyst with an average return of 15.8% and a 61.1% success rate. Gill covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Alignment Healthcare, and Bright Health Group.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AmerisourceBergen with a $155.08 average price target, implying a 9.5% upside from current levels. In a report issued on February 3, Cowen & Co. also maintained a Buy rating on the stock with a $165.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BDX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed